glp 1 and osteoporosis GLP-1 weight loss drugs could increase risk of gout, new research finds GLP-1 Medications + Bone Health

Fisher exact test was performed to determine if there were any differences in symptom frequency among GLP-1 RAs

For the study, which was published in the journal Molecular and Cellular Neuroscience , researchers reviewed findings from 30 preclinical studiesmostly on animals and cellsthat looked at the impact on signs of Alzheimers disease of four GLP-1 receptor agonists: liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), exenatide (Byetta), and dulaglutide (Trulicity)

Overall, current data support a favorable benefitrisk profile despite persistent precautionary carcinogenicity warnings

1 Morphine was used based on the consideration that it represents the gold standard for potent analgesia